References
American Psychiatry Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington: American Psychiatric Publishing.
Halpern, J. H., Lerner, A. G., & Passie, T. (2018). A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD. Current Topics in Behavioral Neurosciences, 36, 333–360.
Lev-Ran, S., Feingold, D., Frenkel, A., & Lerner, A. G. (2014). Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: A preliminary investigation. Journal of Dual Diagnosis, 10(2), 79–83.
Lev-Ran, S., Feingold, D., Rudinski, D., Katz, S., & Arturo, L. G. (2015). Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation. The American Journal on Addictions, 24(3), 197–199.
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M., Lorusso, M., Giannantonio, M., & Lerner, A. G. (2018). Hallucinogen persisting perception disorder: Etiology, clinical features, and therapeutic perspectives. Brain Sciences, 8(3):47.
Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017). The "endless trip" among the NPS users: Psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A Systematic Review. Frontiers in Psychiatry, 8, 240.
Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics, 14(4), 295–314.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nutting, S., Bruinsma, T., Anderson, M. et al. Psychotic and Still Tripping—Hallucinogen Persisting Perception Disorder and First Break Psychosis in an Adolescent. Int J Ment Health Addiction 19, 2440–2442 (2021). https://doi.org/10.1007/s11469-020-00338-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11469-020-00338-5